Annotating the Role of 18F‑FDG PET/CT in Fibromatoses: A Benign Masquerader of Malignancies—Is It Really an Advantageous Tool?
10.1007/s13139-024-00846-5
- Author:
Srinivas Ananth KUMAR
1
;
Harmandeep SINGH
;
Lileswar KAMAN
;
Ritambhra NADA
;
Bhagwant Rai MITTAL
Author Information
1. Department of Nuclear Medicine and PET/CT, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India
- Publication Type:CASE REPORT
- From:Nuclear Medicine and Molecular Imaging
2024;58(3):140-146
- CountryRepublic of Korea
- Language:English
-
Abstract:
Fibromatoses are a heterogeneous group of benign proliferating fibroblasts and myofibroblasts which have a high predilection for recurrence and local invasion, especially deep fibromatoses or desmoid fibromatosis. 18F-FDG PET/CT, the workhorse of oncological imaging in nuclear medicine, can be employed to figure out the nature and aggressiveness of the lesions and various sites of involvement and to monitor treatment response to systemic therapies like tyrosine kinase inhibitors in case of deep or desmoid fibromatoses which is shown in the current research work.
